Journal of Histochemistry & Cytochemistry · 2005 · 33 citations · 5 references
MedicineCell BiologyObstetricsEmbryologyMaternal-fetal MedicinePrenatal DiagnosisInvasive Prenatal TestingPregnancy DiagnosisDna In Situ HybridizationEnrichment Of Rare CellsFetal Tissue-derived CellsIn Vitro Cell ExpansionNon-invasive Prenatal TestingPrenatal Sex Determination
Prenatal diagnosis based on rare fetal cells in maternal blood is currently not a feasible option. An effort was made to improve cell yields by targeting trophoblast cells. After sorting, the HLA-G-positive cell fraction was analyzed directly or after culture. In situ hybridization technology was applied to prove fetal cell source in samples from women carrying a male fetus and to predict gender in samples without previous knowledge of fetal sex. In vitro culture led to a significant increase in fetal cells and accurate gender prediction in 93% of these samples. This approach might be useful for non-invasive prenatal diagnosis.
5
Esther Guetta, Daphna Gordon, Michal J. Simchen et al. · Blood Cells Molecules and Diseases · 2003 · 73 citations
Medicine, Hematology, Obstetrics +16